PharmaDeliver seeks to enter drone delivery to increase deliveries by 15% and achieve $7B annual profit. The case walks through capacity analysis of adding drone delivery, valuation of a partnership with DroneCo vs. acquisition of competitor Fly Away, requiring NPV calculations and risk assessment.
Key Insights:
- Capacity planning: Calculate current delivery volumes by day-of-week and product type, then determine incremental capacity from drone delivery
- Partnership vs. acquisition trade-off: Partnership with DroneCo ($38.75B NPV) vs. acquisition of Fly Away ($39.75B NPV), but acquisition carries regulatory risk
- Regulatory risk in emerging industries: Drone delivery is not mature; acquisition value depends on favorable regulatory outcomes
- Margin-based profitability: Different profit margins per delivery by day-of-week must be incorporated into volume calculations